RongCan Biotech Plans to Cooperate with Zhangjiang Hi-tech Park to Set Up a Management Headquarter

Focusing on the development and industrialization of nucleic acid medicines

Focusing on the development and industrialization of nucleic acid medicines

Focusing on the development and industrialization of nucleic acid medicines

Possesses a proprietary RNA-based Therapeutic Platform (RTP) independently developed for nucleic acid medicines

RongCan Biotech Plans to Cooperate with Zhangjiang Hi-tech Park to Set Up a Management Headquarter

Date : 2021-10-25

Prev : RongCan Biotech Plans to Initiate Series A Financing Round

Next : RongCan’s Pilot Test Base in Minhang Guanghua Industrial Park Was Officially Put into Operation